Prosecution Insights
Last updated: October 04, 2026

Morrison & Foerster LLP

Technology area: Biotechnology & Pharmaceuticals

351 pending office actions • 176 clients • 316 examiners • 156 art units • 0 of 351 (0%) have an AI response strategy ready

Analysis

MORRISON & FOERSTER LLP is a patent law firm with a large practice in Biotechnology & Pharmaceuticals, having handled 23977 career applications. The firm reports a resolved allowance rate of 78.45 percent. Prosecution typically requires an average of 3.43 office actions per allowance to reach a grant.

There are 285 pending office actions currently active. The 3.43 average office actions per allowance indicates a standard level of negotiation with patent examiners in the Biotechnology & Pharmaceuticals sector. This data is supported by a massive volume of 23977 career applications.

The 78.45 percent allowance rate demonstrates the firm's ability to navigate the complexities of pharmaceutical prosecution. Practitioners can anticipate a moderate number of prosecution cycles based on the 3.43 average office actions per allowance. The 285 pending office actions show the firm's significant ongoing commitment to this technical field.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=23977 apps, methodology: how we score firms)

78.4%
Allowance Rate
n=23977
+0.56σ
Allowance Rate (norm)
n=23977
3.4
OAs to Allowance
n=12780
-0.06σ
OAs to Allow (norm)
n=12780
1112 days
Time to Allowance
n=12780
+13.9pp
Interview Lift
n=23977
27.7%
RCE Rate
n=23977
1.3%
Appeal Rate
n=23977

Rejection Performance (% of received rejections ultimately overcome)

74.9%
§101 Overcome
n=1547
77.0%
§102 Overcome
n=4724
77.8%
§103 Overcome
n=7730
79.6%
§112 Overcome
n=6187

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
22%
Top-3 CPC Share
n=23977
81
Practitioners
n=23977
296.0
Apps / Practitioner
n=23977

Portfolio Summary

351
Total Pending OAs
235
Non-Final OAs
111
Final Rejections
5
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 116 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

60
Overdue
9
Due this week
31
Due this month
13
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 116 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (60)Due ≤ 7 days (9)Due ≤ 30 days (31)Due ≤ 60 days (13)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

167
Hard (48%)
145
Medium (41%)
33
Easy (9%)
6
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only7 (2%)
§101 + other53 (15%)
§103 only101 (29%)
§102 only10 (3%)
§112 only28 (8%)
Double-patenting only5 (1%)
Double-patenting + other34 (10%)
Multi-statute (no §101)107 (30%)
No statute on record6 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

159
Life Sciences
45% of docket
26
Information Tech
7% of docket
16
Communications
5% of docket
8
Semiconductors
2% of docket
77
Mechanical / Eng
22% of docket
65
Business / Other
19% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

3,510 h
Manual time on pending OAs
702 h
Time saved (low, 20%)
1,228 h
Time saved (mid, 35%)
30.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAGE, BRENT T 3 82.4% +10.8%
RAHMAN, MASUDUR 3 72.7% +31.7%
PEEBLES, KATHERINE 3 35.5% +48.6%
CHATTERJEE, JAYANTA 3 45.5% +80.0%
LULTSCHIK, WILLIAM G 2 22.3% +31.3%
ZHENG, LI 2 83.6% +12.9%
STEPHENS, REBECCA JOHANNA 2 67.3% +29.3%
SHEN, YANXIN NMN 2 90.0% +22.5%
NGUYEN, NGHI V 2 53.6% +50.8%
MEADOWS, CHRISTINA L 2 76.1% +23.2%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18755523 PLANTS WITH INCREASED WATER USE EFFICIENCY ZHENG, LI 17d overdue
19223728 LETTUCE VARIETY 'SAN ANGELO' ZHENG, LI —
18972633 SOYBEAN VARIETIES PAGE, BRENT T —
18972620 SOYBEAN VARIETIES '2984004', '2987413', AND '2987331' PAGE, BRENT T —

Hard Cases (167)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17798824 METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA BERKE-SCHLESSEL, DAVID W 259d overdue
17941369 SYSTEMS AND METHODS FOR ONBOARDING AND SUPPORTING CREDIT PRODUCT PARTNERS GREGG, MARY M 167d overdue
18368303 ADAPTIVE SELECTION OF STIMULI FOR NEURO-ACTIVATION SAHAND, SANA 164d overdue
18143989 ADAPTIVE SELECTION OF MESSAGES FOR TRANSMISSION IN NETWORKED ENVIRONMENTS TO INCREASE SESSION ADHERENCE HOLCOMB, MARK 128d overdue
19055495 MODULAR- SEQUENTIAL- HIGH-TEMPERATURE HEAT COLLECTION AND STORAGE DEVICE WITH INTEGRATED POWER CONVERSION UNIT LARGI, MATTHEW THOMAS 126d overdue
17428591 ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF PEEBLES, KATHERINE 124d overdue
18357613 SYSTEMS AND METHODS FOR HUMAN-MACHINE PARTNERED PTSD PREDICTION EDWARDS, PHILIP CHARLES 98d overdue
18174000 INTELLIGENT SYSTEMATIC AGENT: AN ENSEMBLE OF DEEP LEARNING AND EVOLUTIONARY STRATEGIES SUSSMAN MOSS, JACOB ZACHARY 66d overdue

Interview Candidates (24)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17428591 ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF PEEBLES, KATHERINE 124d overdue
18272786 GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF RISPERIDONE PEEBLES, KATHERINE 88d overdue
18541719 SYNTHETIC ACTIVATION OF MULTIMERIC TRANSMEMBRANE RECEPTORS CHATTERJEE, JAYANTA 26d overdue
18298998 METHODS OF SCREENING FOR PLANT GAIN OF FUNCTION MUTATIONS AND COMPOSITIONS THEREFOR CHATTERJEE, JAYANTA 22d overdue
18755523 PLANTS WITH INCREASED WATER USE EFFICIENCY ZHENG, LI 17d overdue
18715424 TOOLS FOR GENE SILENCING CHATTERJEE, JAYANTA 5d
17599446 EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS RAHMAN, MASUDUR 7d
19231374 DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY LULTSCHIK, WILLIAM G 62d

Client Portfolio (176 clients)

Client (Assignee)Pending OAs
Stryker 38
PwC 16
Click Therapeutics 14
The MITRE Corporation 12
Petrobras 12
Bayer 7
Tropic Biosciences UK Limited 5
Stack AV Co. 5
Toray 5
Nortiva Bio, Inc. 5
DNA SCRIPT 5
Ajou University 5
GDM Seeds 4
SNIPR BIOME APS 4
University of California 4
Aarhus Universitet 4
Rakuten 4
Exowatt 3
Malvern Panalytical Limited 3
Dynavax Technologies 3
Chengdu Ruimu Biopharmaceuticals 3
Hofseth Biocare 3
NOBLIS, INC. 3
Roche 3
ADAGENE INC. 3
TALENGEN INTERNATIONAL LIMITED 3
VoxelSensors SRL 2
Asociados Don Mario S.A. 2
Inhibrx Biosciences, Inc. 2
Cytokinetics, Incorporated 2
GENENTECH, INC. 2
BAE Systems 2
Prism Inks, Inc. 2
Hbc Immunology Inc. 2
Peking University 2
An2 Therapeutics, Inc. 2
Syntis Bio, Inc. 2
INNOVENT BIOLOGICS (SUZHOU) CO., LTD. 2
Genmab 2
BEIJING INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE 2
BRADKEN RESOURCES PTY LIMITED 2
Tacit Therapeutics, Inc. 2
MAZE THERAPEUTICS, INC. 2
Devron Corporation 2
Deutsches Krebsforschungszentrum 2
Argonaut Manufacturing Services 2
PROTEOMETECH INC. 2
Umoja BioPharma, Inc. 2
AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH 2
Terviva, Inc. 2
HRYZ Biotech 2
AEM Singapore Pte. Ltd. 1
Therorna Inc. 1
Avalo 1
Neural Enterprises Inc. 1
Salinas Valley Seeds, LLC 1
NATIONAL CHUNG HSING UNIVERSITY 1
2NO, Inc. 1
Nomadix, Inc. 1
Ohalo Genetics, Inc. 1
Pinnacle Seed, Inc. 1
Uncaged Innovations Inc. 1
University of Chicago 1
Tutor Intelligence, Inc. 1
Shenzhen Institute Of Advanced Technology 1
ATR Brands 1
Atmospheric & Space Technology Research Associates, L.L.C. 1
Supporting Initiatives to Redistribute Unused Medicine (Sirum) 1
SpringRose, Inc. 1
Matter Neuroscience Inc. 1
Sublime Systems, Inc. 1
Native Pet, Inc. 1
Aster 1
INFINANT HEALTH, INC 1
I Of The Tiger, Inc. 1
Aerorx Therapeutics, Inc. 1
Gdc Technology (Shenzhen) Limited 1
Hearth Display Inc. 1
Participant Assistive Products 1
Niab 1
Stablegrid Engineers GmbH 1
Ethadox Ltd. 1
Amgen 1
Huidagene Therapeutics (Singapore) Pte. Ltd. 1
Elixirgen Therapeutics 1
Forest Neurotech, LLC 1
CIBUS EUROPE B.V. 1
Wall to Wall, LLC 1
Chinese Academy of Sciences 1
ELICIT PLANT 1
Frontier Medicines 1
UNIVERSITÄTSKLINIKUM ESSEN 1
Immunoracle Inc. 1
Commonwealth Scientific and Industrial Research Organisation 1
Bayer Akiengesellschaft 1
EpicentRx 1
American Ag Energy, Inc. 1
Oxitec Limited 1
Onelogy Inc. 1
ePlant 1
Edigene Therapeutics (Beijing) Inc. 1
Triovance Holding LLC 1
MIT 1
Tune Therapeutics, Inc. 1
UNISA VENTURES PTY LTD 1
Zhejiang Genfleet 1
Fender Musical Instruments Corporation 1
University of Illinois 1
Zhejiang Jiachi Development Pharmaceuticals Ltd. 1
SOFTBANK CORP. 1
Plexbio Co., Ltd. 1
CITRYLL B.V. 1
Attralus, Inc. 1
Tayu Huaxia Biotech Medical Group Co., Ltd. 1
Gyre Therapeutics, Inc. 1
Dhruvajyoti Roy 1
Bluenalu, Inc. 1
GeoComply Solutions Inc. 1
Analex Corporation 1
TRIASTEK, INC. 1
Folium Food Science 1
Immunowake Inc. 1
DYNAMICURE BIOTECHNOLOGY LLC 1
BIOAPPLICATIONS INC 1
Allygen Group 1
Curara AB 1
Verogen, Inc. 1
Health Technology Innovations 1
Aurinia Pharmaceuticals 1
Gramercy Group Inc. 1
Babylat 1
Viromissile, Inc. 1
UNIVERSITÄTSSPITAL BASEL 1
Mechanobiologics, Inc. 1
Children's Medical Research Institute 1
Shionogi & Co., Ltd. 1
Proteas Bioanalytics, Inc. 1
University of Cyprus 1
The Board Of Trustees Of University Of Illinois 1
Asher Biotherapeutics 1
Research Foundation To Cure Aids, Inc. 1
Shanghai Microdom Biotech Co., Ltd 1
Universidade Federal do Rio de Janeiro 1
Trayt Health Inc. 1
Neuropore Therapies, Inc. 1
Teal Bio, Inc. 1
Stoic Bio, Inc. 1
Resolution Therapeutics Limited 1
Kira Pharmaceuticals (Suzhou) Ltd. 1
Children's Hospital Los Angeles 1
BOCO Silicon Valley, Inc. 1
Soongsil University 1
CNPEM - CENTRO NACIONAL DE PESQUISA EM ENERGIA E MATERIAIS 1
Nucleus Biologics 1
Sorbonne Université 1
Arkestro 1
Centro Brasileiro De Pesquisas Físicas - CBPF 1
Stilla Technologies 1
Cefo Co., Ltd. 1
UNIVERSITY HEALTH NETWORK 1
Mercury Financial Holdings LLC 1
Celgene 1
Baidu 1
BEIJING CONTINENT PHARMACEUTICALS CO., LTD. 1
Minotaur Therapeutics, Inc. 1
Haemalogix Ltd. 1
Elemind Technologies, Inc. 1
Servico Nacional De Aprendizagem Industrial - Departamento Regional De Santa Catrina Sanai/Sc 1
New Culture Inc. 1
Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v. 1
TURNSTONE BIOLOGICS CORP. 1
University of Essex Enterprises Limited 1
Julius-Maximilians-Universität Würzburg 1
Avive 1
CLICK THERAPEUTICS, INC. 1
GENOME RESEARCH LIMITED 1

Top Art Units

Art UnitApps
166311
16629
37977
37955
16175
16745
16435
16374
36824
16524

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19431636 SYSTEMS AND METHODS FOR HIGHLY-PARALLEL TESTING WITH THERMAL CONTROL Aem Singapore Pte. Ltd. VELEZ, ROBERTO 2858 §102§103 Final Rejection — Pending Dec 23, 2025
19399542 METHODS OF FORMING CIRCULARIZED RNA Therorna Inc. ANGELL, JON E 1637 §102§103§112 Non-Final OA — Pending Nov 24, 2025
19288455 MANAGEMENT AND COORDINATION OF DATA FOR DIGITAL THERAPEUTICS TRIALS Click Therapeutics, Inc. EZEWOKO, MICHAEL I §101§103 Non-Final OA — Pending Aug 01, 2025
19283037 SYSTEM AND METHOD FOR SPECTRAL DATA ANALYSIS Avalo, Inc. VARNDELL, ROSS E 2674 §103 Non-Final OA — Pending Jul 28, 2025
19245212 UNIFIED COMMUNICATION AND EQUIPMENT TRACKING MOBILE APPLICATION FOR MEDICAL ENVIRONMENTS Stryker Corporation GARTLAND, SCOTT D 3683 §101§103§112 Non-Final OA — Pending Jun 20, 2025
19240156 OPERATING DEVICES IN AN OPERATING ROOM Stryker Corporation SOREY, ROBERT A §103 Non-Final OA — Pending Jun 17, 2025
19236768 REJECTING SPURIOUS MAGNETIC FIELDS DURING MAGNETIC MARKER LOCALIZATION Stryker Corporation CELESTINE, NYROBI I 3793 §102§103§112 Final Rejection — Pending Jun 12, 2025
19231374 DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY Click Therapeutics, Inc. LULTSCHIK, WILLIAM G 3682 §101§103 Non-Final OA 62d Pending Jun 06, 2025
19231379 DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY Click Therapeutics, Inc. GEBREMICHAEL, BRUK A 3715 §103 Non-Final OA 98d overdue Pending Jun 06, 2025
19227872 SYSTEMS AND METHODS FOR 3D MODEL BASED DRONE FLIGHT PLANNING AND CONTROL Neural Enterprises Inc. BEAN, JARED C §103Other Non-Final OA — Pending Jun 04, 2025
19223728 LETTUCE VARIETY 'SAN ANGELO' Salinas Valley Seeds, LLC ZHENG, LI 1662 §112 Non-Final OA — Pending May 30, 2025
19216652 SYSTEMS AND METHODS FOR DETERMINING TIMING FOR FLUORESCENCE BASED BLOOD FLOW ASSESSMENT Stryker Corporation ALDARRAJI, ZAINAB MOHAMMED 3797 §102§103 Non-Final OA — Pending May 22, 2025
19216441 NEIGHBORHOOD-GATED SWITCHING PIXEL SENSOR Voxelsensors Srl FOSSELMAN, JOEL W §102§103 Non-Final OA — Pending May 22, 2025
19216373 ENGINEERING CASSAVA FOR IMPROVED GROWTH AND YIELD National Chung Hsing University KEOGH, MATTHEW R §102§103§112 Non-Final OA — Pending May 22, 2025
19215928 SOYBEAN VARIETY '20506064' Gdm Seeds Inc. STEPHENS, REBECCA JOHANNA §112 Non-Final OA — Pending May 22, 2025
19210663 MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION Tropic Biosciences UK Limited PAGE, BRENT T 1663 §101§102DP Non-Final OA — Pending May 16, 2025
19207213 PRIVACY-CONSCIOUS CONTENT AND ADVERTISEMENT TARGETING 2No, Inc. BEKERMAN, MICHAEL 3621 §101§102§103§112 Non-Final OA 41d Pending May 13, 2025
19126628 REMOVAL TOOL FOR MAGNETIC LOCALIZATION MARKER Stryker Corporation KLEIN, BROOKE L 3797 §103 Final Rejection — Pending May 01, 2025
19189060 TRAVELER TRACKING SYSTEM Nomadix, Inc. VANDERHORST, MARIA VICTORIA §101§103Other Non-Final OA — Pending Apr 24, 2025
19181163 POLYPLOID HYBRID MAIZE BREEDING Ohalo Genetics, Inc. STEPHENS, REBECCA JOHANNA §112DP Non-Final OA — Pending Apr 16, 2025
19173408 SWISS CHARD VARIETY 'RHDF-611 23' Pinnacle Seed, Inc. RADOSAVLJEVIC, ALEKSANDAR §112 Non-Final OA — Pending Apr 08, 2025
19090231 PLANT PROTEIN BASED IMITATION LEATHER FABRIC Uncaged Innovations Inc. IMANI, ELIZABETH MARY COLE 1789 §103 Non-Final OA — Pending Mar 25, 2025
19086929 ENGINEERED RNA DEMETHYLASES FOR IMPROVED PLANT GROWTH The University of Chicago SHEN, YANXIN NMN §102§103§112 Non-Final OA — Pending Mar 21, 2025
19079832 SYSTEMS AND METHODS FOR TRANSMITTING MEDICAL VIDEO DATA IN A BANDWIDTH CONSTRAINED ENVIRONMENT Stryker Corporation OCAK, ADIL 2426 §103 Non-Final OA — Pending Mar 14, 2025
19109411 VISUAL ROBOTIC TASK CONFIGURATION SYSTEM Tutor Intelligence, Inc. LIN, ABBY YEE §103 Non-Final OA — Pending Mar 06, 2025
18722586 LEATHER-LIKE BIOLOGICAL COMPOSITE MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Institute Of Advanced Technology ZHANG, MICHAEL N §112 Non-Final OA — Pending Feb 21, 2025
19055495 MODULAR- SEQUENTIAL- HIGH-TEMPERATURE HEAT COLLECTION AND STORAGE DEVICE WITH INTEGRATED POWER CONVERSION UNIT Exowatt, Inc. LARGI, MATTHEW THOMAS 3746 §102§103§112 Final Rejection 126d overdue Pending Feb 17, 2025
19055493 COATINGS TO RESIST HIGH-TEMPERATURE OXIDATION IN A THERMAL ENERGY STORAGE SYSTEM Exowatt, Inc. TANENBAUM, TZVI SAMUEL §103§112 Non-Final OA — Pending Feb 17, 2025
19103139 SUITCASE FRAME Atr Brands Limited TAMIL, JESSICA KAVINI 3733 §103§112 Final Rejection 16d Pending Feb 11, 2025
19046351 ITERATIVE RAY-TRACING FOR AUTOSCALING OF OBLIQUE IONOGRAMS Atmospheric & Space Technology Research Associates, L.L.C. LEE, SARAH YEO Other Non-Final OA — Pending Feb 05, 2025
19039724 CHAOTIC STORAGE OF PRESCRIPTION MEDICATIONS Supporting Initiatives to Redistribute Unused Medicine (Sirum) ALDERSON, ANNE-MARIE K 3682 §103 Final Rejection 28d overdue Pending Jan 28, 2025
18998440 PARTICLE CHARACTERISATION Malvern Panalytical Limited LUU, THANH X §102§103 Non-Final OA — Pending Jan 24, 2025
19030691 METHOD AND APPARATUS FOR KNOWLEDGE REPRESENTATION AND REASONING IN ACCOUNTING Pwc Product Sales LLC LU, KUEN S 2165 §103 Final Rejection 20d Pending Jan 17, 2025
19030862 SYSTEMS AND METHODS FOR MEDICAL IMAGING USING A ROLLING SHUTTER IMAGER Stryker Corporation BROWN JR, HOWARD D 2488 §103Other Non-Final OA 2d overdue Pending Jan 17, 2025
19021965 SYSTEMS AND METHODS FOR UNDERWEAR FOR USE WITH LIMITED MOBILITY Springrose, Inc. NUNNERY, GRADY ALEXANDER 3732 §103 Non-Final OA 42d Pending Jan 15, 2025
19018259 SYSTEMS AND METHODS FOR EVALUATING AND IMPROVING NEUROTRANSMITTER LEVELS BASED ON MOBILE DEVICE APPLICATION DATA Matter Neuroscience Inc. KUO, JONATHAN T DP Non-Final OA — Pending Jan 13, 2025
19007181 METHODS AND SYSTEMS FOR NATURAL LANGUAGE PROCESSING OF GRAPH DATABASE QUERIES The MITRE Corporation HUANG, CHENG-FENG 2497 §103 Non-Final OA — Pending Dec 31, 2024
19002403 SYSTEMS AND METHODS FOR IMAGE SEQUENCE REGISTRATION Stryker Corporation FUJITA, KATRINA R §102§103 Non-Final OA — Pending Dec 26, 2024
18878340 LOW VOLTAGE ELECTROLYZER AND METHODS OF USING THEREOF Sublime Systems, Inc. WILKINS III, HARRY D 1794 §102§103 Non-Final OA 30d Pending Dec 23, 2024
18983728 CANISTER WITH A PUMP FOR DISPERSING LIQUIDS AND METHOD OF USING THE SAME Native Pet, Inc. PANCHOLI, VISHAL J §103§112 Non-Final OA — Pending Dec 17, 2024
18983117 PIXEL SENSOR SYSTEM Voxelsensors Srl KO, TONY §102 Non-Final OA — Pending Dec 16, 2024
18873638 IDENTIFICATION AND CHARACTERIZATION OF PANCREATIC CYSTIC LESIONS BAYER AKTIENGESELLSCHAFT VILLECCO, JOHN M §101§102 Non-Final OA — Pending Dec 10, 2024
18974551 COIL UNIT, STATOR MEMBER, STATOR, MOTOR, AND MANUFACTURING METHOD FOR COIL UNIT, STATOR MEMBER, STATOR, AND MOTOR Aster Co., Ltd. ROJAS, BERNARD §102§103 Non-Final OA — Pending Dec 09, 2024
18972633 SOYBEAN VARIETIES Asociados Don Mario S.A. PAGE, BRENT T 1663 §112 Non-Final OA — Pending Dec 06, 2024
18972620 SOYBEAN VARIETIES '2984004', '2987413', AND '2987331' Asociados Don Mario S.A. PAGE, BRENT T 1663 §112 Non-Final OA — Pending Dec 06, 2024
18969101 MULTISPECIFIC POLYPEPTIDE CONSTRUCTS CONTAINING A CONSTRAINED CD3 BINDING DOMAIN AND A RECEPTOR BINDING REGION AND METHODS OF USING THE SAME Inhibrx Biosciences, Inc. CHEONG, CHEOM-GIL §103§112DP Non-Final OA — Pending Dec 04, 2024
18962355 MACHINE LEARNING ARCHITECTURES TO DETERMINE USER RESPONSIVENESS BASED ON MULTI-MODAL MEASUREMENT DATA Click Therapeutics, Inc. VANDER WOUDE, KIMBERLY ELAINE 3681 §101§103 Non-Final OA — Pending Nov 27, 2024
18866477 ULTRASOUND-BASED 3D LOCALIZATION OF FIDUCIAL MARKERS OR SOFT TISSUE LESIONS Stryker Corporation PENG, BO JOSEPH 3797 §102§103 Final Rejection 42d Pending Nov 15, 2024
18948914 MEDICAL DEVICES WITH RE-JOINABLE HOUSINGS Stryker Corporation IGBOKO, CHIMA U 3771 §102 Non-Final OA — Pending Nov 15, 2024
18948005 METHOD AND APPARATUS FOR ACCESSING THE INTERIOR OF A HIP JOINT, INCLUDING THE PROVISION AND USE OF A NOVEL TELESCOPING ACCESS CANNULA AND A NOVEL TELESCOPING OBTURATOR Stryker Corporation BECCIA, CHRISTOPHER J 3775 §103Other Non-Final OA — Pending Nov 14, 2024
18862138 BICYCLIC PIPERAZINONES AND THERAPEUTIC USES THEREOF Cytokinetics, Inc. KENYON, JOHN S §112 Non-Final OA — Pending Oct 31, 2024
18928962 SYSTEMS AND METHODS FOR SURGICAL SMOKE MANAGEMENT Stryker Corporation SHIN, SOO JUNG §102§103§112Other Non-Final OA — Pending Oct 28, 2024
18859952 DRUG PRODUCTION METHOD Genentech, Inc. GAVIN, KRISTIN ELIZABETH 3624 §101§103 Non-Final OA 40d Pending Oct 24, 2024
18917304 TRANSIENT COMMENSAL MICROORGANISM FOR IMPROVING GUT HEALTH Infinant Health, Inc. NGUYEN, NGHI V §103DP Non-Final OA — Pending Oct 16, 2024
18913694 SYSTEM FOR PROVIDING DATA AND USER INTERFACES FOR A MULTI-ROUND MULTIPLAYER PREDICTION GAME I Of The Tiger, Inc. D'AGOSTINO, PAUL ANTHONY §101§102 Non-Final OA — Pending Oct 11, 2024
18913598 SYSTEMS AND METHODS FOR DETECTING AND MONITORING UNMANNED AERIAL SYSTEMS The MITRE Corporation PHILIPPE, GIMS S 2424 §103 Non-Final OA — Pending Oct 11, 2024
18855961 DRIVE SPROCKET MEMBER FOR AN ENDLESS TRACK OF A TRACKED VEHICLE BAE Systems PLC ROGERS, ADAM D §102§103§112 Non-Final OA — Pending Oct 10, 2024
18911037 SIMULATOR FOR A VEHICLE PLANNING SYSTEM Stack Av Co. WANG, JINGLI 3666 §103 Final Rejection — Pending Oct 09, 2024
18899969 Single Axis Solar Collector Array Exowatt, Inc. BUCK, LINDSEY A 1728 §102§103§112 Non-Final OA 23d overdue Pending Sep 27, 2024
18852135 LIQUID FORMULATIONS OF INDACATEROL AND GLYCOPYRRONIUM Aerorx Therapeutics, Inc. HASTINGS, ALISON AZAR §103Other Non-Final OA — Pending Sep 27, 2024
18900539 SYSTEMS, DEVICES, AND METHODS FOR ENCODING AND PLAYBACK OF HIGHER RESOLUTION DIGITAL CINEMA CONTENT Gdc Technology (Shenzhen) Limited LIMA, FABIO S 2486 §103 Non-Final OA — Pending Sep 27, 2024
18897698 INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS Prism Inks, Inc. CHI, AMANDA LYNN §103§112 Non-Final OA — Pending Sep 26, 2024
18897923 SOYBEAN VARIETIES '22069573', '22041167', '22139831', AND '22041260' Gdm Seeds Inc. MEADOWS, CHRISTINA L 1663 §112 Non-Final OA — Pending Sep 26, 2024
18897832 SOYBEAN VARIETIES '21808296', '22072900', '22073013', '21776234', '21776245', '22073192', '21774873', '22032860', AND '22033238' Gdm Seeds Inc. MEADOWS, CHRISTINA L 1663 §112 Non-Final OA — Pending Sep 26, 2024
18894800 CURVED PHASED ARRAY ANTENNA The MITRE Corporation WINDRICH, MARCUS E §103§112 Non-Final OA — Pending Sep 24, 2024
18891965 SYSTEMS, METHODS, AND DEVICES FOR BEHAVIOR-DRIVEN INSIGHTS Hearth Display Inc. MANSFIELD, THOMAS L 3624 §101§103 Final Rejection — Pending Sep 20, 2024
18890450 USE OF NANOFLUID TO REMOVE OIL AND SALTS FROM ROCK SAMPLES IN PETROLEUM SYSTEMS Petróleo Brasileiro S.A. - Petrobras MERCADO, ALEXANDER A 2855 §102 Final Rejection — Pending Sep 19, 2024
18889769 NAME AND FACE MATCHING The MITRE Corporation HO, HUY C §102DP Non-Final OA — Pending Sep 19, 2024
18890364 WHEELCHAIR WHEEL LOCK WITH ENHANCED DURABILITY Participant Assistive Products RODRIGUEZ, PAMELA §102§103 Non-Final OA — Pending Sep 19, 2024
18816990 METHODS OF GENETICALLY ALTERING A PLANT NIN-GENE TO BE RESPONSIVE TO AUXIN Niab ZHONG, WAYNESHAOBIN 1662 §102§103§112 Non-Final OA — Pending Aug 27, 2024
18812733 SYSTEMS AND METHODS FOR GENERATING DYNAMIC GRAPHICAL USER INTERFACES FOR MONITORING AND CONTROLLING CONNECTED DEVICES Stryker Corporation CALDERON SANTIAGO, ALVARO RAFAEL §103 Non-Final OA — Pending Aug 22, 2024
18811218 GENERATION OF TEST SCRIPTS AND REPORTS FOR VERIFYING AND VALIDATING APPLICATIONS USING GENERATIVE MODELS Click Therapeutics, Inc. PAULINO, LENIN 2197 §103 Final Rejection — Pending Aug 21, 2024
18840149 SYSTEM FOR STABILIZING ELECTRICITY GRIDS, HAVING CAVERNS FOR GAS STORAGE Stablegrid Engineers GmbH MIAN, SHAFIQ A 2834 §102§103 Non-Final OA — Pending Aug 21, 2024
18811618 COMPOSITIONS AND METHODS FOR BIODEGRADING ALCOHOL Ethadox Ltd. TSAY, MARSHA M 1656 §103 Non-Final OA — Pending Aug 21, 2024
18799387 DELIVERY OF MULTI-LAYER DIGITAL THERAPY TO USERS FOR ADDRESSING FUNCTIONAL IMPAIRMENT Click Therapeutics, Inc. COVINGTON, AMANDA R 3686 §101 Final Rejection 28d Pending Aug 09, 2024
18799789 THERMOPLASTIC COMPOSITES WITH IMPROVED INDUCTION HEATING PROPERTIES Toray Advanced Composites BLADES, JOHN A §102§103 Non-Final OA — Pending Aug 09, 2024
18835932 PARTICLE ANALYSIS Malvern Panalytical Limited AHMED, JAMIL 2877 §103 Final Rejection — Pending Aug 05, 2024
18782534 SPATIAL AUDIO ALERTS FOR DRIVER-ASSIST SYSTEMS IN TRUCKS Stack Av Co. BRINEY III, WALTER F 2692 §103 Final Rejection 20d Pending Jul 24, 2024
18832887 SYNTHESIS OF A KIF18A INHIBITOR Amgen, Inc. OH, TAYLOR V §102§112 Non-Final OA — Pending Jul 24, 2024
18832823 NOVEL CRISPR-CAS12I SYSTEMS AND USES THEREOF Huidagene Therapeutics (Singapore) Pte. Ltd. RAHMAN, MASUDUR §112DP Non-Final OA — Pending Jul 24, 2024
18832869 UPREGULATION OF FERRITIN HEAVY CHAIN 1 EXPRESSION Hbc Immunology Inc. VARADARAJ, ARCHANA §101§103§112DP Non-Final OA — Pending Jul 24, 2024
18832867 MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN Hbc Immunology Inc. VARADARAJ, ARCHANA §103§112DP Non-Final OA — Pending Jul 24, 2024
18781814 METHODS AND SYSTEMS FOR IDENTIFYING LYMPH NODES USING FLUORESCENCE IMAGING DATA Stryker Corporation VIRK, ADIL PARTAP S 3798 §103 Non-Final OA 24d overdue Pending Jul 23, 2024
18781464 SYSTEMS AND METHODS FOR CONVERSATION MODELING Pwc Product Sales LLC NEHCHIRI, KOOROSH §103Other Non-Final OA — Pending Jul 23, 2024
18774543 LANE FOLLOWING WITH OBJECT DETECTION FOR AUTONOMOUS VEHICLES Stack Av Co. DYER, ANDREW R 3662 §103 Non-Final OA — Pending Jul 16, 2024
18769203 TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES Elixirgen Therapeutics, Inc. CHESTNUT, BARRY A §103DP Non-Final OA — Pending Jul 10, 2024
18727308 CIRCULAR RNA VACCINES AGAINST SARS-COV-2 VARIANTS AND METHODS OF USE THEREOF Peking University CORNELIUS, CLAIRE ADRIENNE §103§112DP Non-Final OA — Pending Jul 08, 2024
18763680 TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST Snipr Biome Aps RAHMAN, MASUDUR §102§112 Non-Final OA — Pending Jul 03, 2024
18764077 SYSTEMS AND METHODS FOR MEDICAL IMAGING ILLUMINATION Stryker Corporation WOO, JAE KYUN 3795 §103 Final Rejection 4d overdue Pending Jul 03, 2024
18759817 SYSTEMS AND METHODS FOR IMAGING AND MODULATING THE NERVOUS SYSTEM USING AN ULTRASOUND-BASED BRAIN-COMPUTER INTERFACE Forest Neurotech, LLC EDUN, DEAN NAWAAB 3797 §103§112 Non-Final OA — Pending Jun 29, 2024
18757253 PRESENTING MULTIMODAL, MULTISTABLE STIMULI TO REDUCE SYMPTOMS ASSOCIATED WITH ATTENTION BIASES DUE TO IMPAIRMENT OF COGNITIVE FUNCTIONS IN USERS Click Therapeutics, Inc. SANTOS RODRIGUEZ, JOSEPH M §101§112 Non-Final OA — Pending Jun 27, 2024
18756322 ADAPTIVE GENERATION OF PERSONALIZED SCHEDULE FOR DELIVERY OF MESSAGES TO USERS USING MACHINE LEARNING MODELS Click Therapeutics, Inc. NGUYEN, TRAN N 3685 §101§102§103 Non-Final OA — Pending Jun 27, 2024
18755523 PLANTS WITH INCREASED WATER USE EFFICIENCY The Regents of the University of California ZHENG, LI 1662 §103 Non-Final OA 17d overdue Pending Jun 26, 2024
18752480 SHATTERPROOF GENES AND MUTATIONS Cibus Europe, B.V. DEVEAU ROSEN, JASON 1662 §103§112Other Final Rejection 1d overdue Pending Jun 24, 2024
18723407 IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINE Dynavax Technologies Corporation SALVOZA, M FRANCO G §103 Non-Final OA — Pending Jun 21, 2024
18722189 COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA BAYER AKTIENGESELLSCHAFT KUCKLA, ANNA GRACE §103§112 Non-Final OA — Pending Jun 20, 2024
18722233 COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA BAYER AKTIENGESELLSCHAFT RAHMANI, NILOOFAR §102 Non-Final OA — Pending Jun 20, 2024
18747999 Providing Training Through Presentation of Visual Elements to Address Maladaptive Behavior of Users with Skin Pathologies Click Therapeutics, Inc. LULTSCHIK, WILLIAM G 3682 §101§103 Non-Final OA — Pending Jun 19, 2024
18720593 MODIFIED AGROBACTERIA FOR EDITING PLANTS Tropic Biosciences UK Limited DEVEAU ROSEN, JASON 1662 §103 Final Rejection 66d overdue Pending Jun 14, 2024
18720613 INTEGRATED ROOF MODULE AND MODULAR ROOF SYSTEM THEREOF Wall To Wall, LLC HERRING, BRENT W 3633 §102§103§112 Non-Final OA — Pending Jun 14, 2024
18737606 SYMRK PHOSPHORYLATION FOR ROOT NODULE ORGANOGENESIS Aarhus Universitet BENZION, GARY 1681 §103§112 Non-Final OA — Pending Jun 07, 2024
18717976 ENGINEERED CAS12B EFFECTOR PROTEINS AND METHODS OF USE THEREOF Institute Of Zoology, Chinese Academy Of Sciences PAK, YONG D 1652 §103§112 Non-Final OA — Pending Jun 07, 2024
18717660 OPHTHALMIC PREPARATION OF TYROSINE KINASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Chengdu Ruimu Biopharmaceuticals Co., Ltd. VIGIL, TORIANA NICHOLE 1612 §103 Final Rejection — Pending Jun 07, 2024
18716814 COMBINATIONS An2 Therapeutics, Inc. BURKETT, DANIEL JOHN §103§112 Non-Final OA — Pending Jun 05, 2024
18716804 NON-TUBERCULOSIS MYCOBACTERIA INFECTION TREATMENT An2 Therapeutics, Inc. NOLAN, JASON MICHAEL 1623 §103 Non-Final OA — Pending Jun 05, 2024
18734359 ADJUSTABLE ARM MOUNT AND DATA TRANSMISSION MODULE The MITRE Corporation BADAWI, MEDHAT 3642 §103§112 Non-Final OA 44d overdue Pending Jun 05, 2024
18731125 MANUFACTURING METHODS FOR GASTRIC RESIDENCE SYSTEMS Nortiva Bio, Inc. PEEBLES, KATHERINE 1617 §102§103§112DP Non-Final OA — Pending May 31, 2024
18731135 PHYTOSTEROL-BASED AGRICULTURAL COMPOSITION AND THEIR USE Elicit Plant JOHNSON, DANIELLE D 1617 §103§112 Final Rejection — Pending May 31, 2024
18715424 TOOLS FOR GENE SILENCING The Regents of the University of California CHATTERJEE, JAYANTA 1662 §103§112 Final Rejection 5d Pending May 31, 2024
18709292 NOVEL TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TdT) VARIANT AND USES THEREOF Dna Script ROBINSON, HOPE A 1652 §103§112 Final Rejection — Pending May 10, 2024
18707499 KRAS G12C INHIBITORS Frontier Medicines Corporation RAHMANI, NILOOFAR 1691 §112 Non-Final OA — Pending May 03, 2024
18653080 SYSTEMS AND METHODS FOR QUERYING GRAPH DATABASES USING NATURAL LANGUAGE QUERIES The MITRE Corporation ASPINWALL, EVAN S 2152 §103 Non-Final OA 29d overdue Pending May 02, 2024
18706631 SYNTHETIC CONTRAST-ENHANCED MR IMAGES UNIVERSITÄTSKLINIKUM ESSEN LANGHALS, RENEE C 3797 §103§112 Non-Final OA 29d Pending May 01, 2024
18704409 METHODS OF ANALYZING A SAMPLE FOR CANCER-SPECIFIC IMMUNE CELLS Immunoracle Inc. IVICH, FERNANDO NMN §101§102§103§112DP Non-Final OA — Pending Apr 24, 2024
18640830 SYSTEMS AND METHODS FOR GENERATING INSIGHTS INTO OPERATIONAL DATA USING A LANGUAGE MODEL Pwc Product Sales LLC BROCKINGTON III, WILLIAM S 3623 §103§112 Non-Final OA 29d Pending Apr 19, 2024
18703299 COMPOSITIONS AND METHODS FOR PRODUCING AROMAS Commonwealth Scientific And Industrial Research Organisation MERCHLINSKY, JOSEPH CULLEN 1791 §102§103§112 Non-Final OA — Pending Apr 19, 2024
18640717 SYSTEMS AND METHODS FOR DETECTING SENSITIVE TEXT IN DOCUMENTS The MITRE Corporation CHUNG, DANIEL WONSUK 2659 §103 Final Rejection — Pending Apr 19, 2024
18639405 ADAPTIVE NETWORKING FOR RESILIENT COMMUNICATIONS The MITRE Corporation FUQUA, CHRISTINE DUONG 2462 §103 Final Rejection 47d Pending Apr 18, 2024
18262637 OPHTHALMIC PREPARATION FOR TREATING MACULAR EDEMA, OPTIC NEURITIS AND NON-INFECTIOUS ENDOPHTHALMITIS THROUGH EYE DROP ADMINISTRATION Chengdu Ruimu Biopharmaceuticals Co., Ltd. TRAN, SUSAN T 1615 §102§103§112Other Final Rejection — Pending Apr 17, 2024
18637281 GEOMETRIC CONFIGURATIONS FOR GASTRIC RESIDENCE SYSTEMS Nortiva Bio, Inc. SONG, INJA 3783 §102§103§112 Non-Final OA — Pending Apr 16, 2024
18636181 SYSTEMS AND METHODS FOR PRE-OPERATIVE VISUALIZATION OF A JOINT Stryker Corporation KANAAN, MAROUN P 3687 §103 Final Rejection 38d overdue Pending Apr 15, 2024
18636183 ADJUSTABLE MOUNT SYSTEMS AND METHODS Stryker Corporation ROBINSON, NICHOLAS A 3798 §103 Final Rejection 4d overdue Pending Apr 15, 2024
18633989 GENERATION OF ARTIFICIAL CONTRAST-ENHANCED COMPUTED TOMOGRAPHY IMAGES Bayer Akiengesellschaft HSU, JONI 2611 §103§112 Non-Final OA — Pending Apr 12, 2024
18629809 ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOF Dynavax Technologies Corporation SHIAO, REI TSANG 1691 DP Non-Final OA — Pending Apr 08, 2024
18699246 SURFACE-MODIFIED DENTAL ZIRCONIA MATERIAL AND METHOD FOR PREPARING SAME Ajou University Industry-Academic Cooperation Foundation WEDDLE, ALEXANDER MARION 1785 §102§103 Non-Final OA — Pending Apr 05, 2024
18628640 SYSTEMS AND METHODS FOR PROVIDING MEDICAL FLUORESCENCE IMAGING WITH A MODULATED FLUORESCENCE EXCITATION ILLUMINATION SOURCE Stryker Corporation FAIRCHILD, AARON BENJAMIN 3795 §102§103§112 Non-Final OA — Pending Apr 05, 2024
18628663 SYSTEMS, METHODS, AND DEVICES FOR REPROCESSING HARMONIC TISSUE CUTTERS Stryker Corporation SHI, KATHERINE MENGLIN 3771 §102§103 Final Rejection 7d Pending Apr 05, 2024
18624625 MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS Epicentrx, Inc. SMITH, PETER DANIEL §102§103§112 Non-Final OA — Pending Apr 02, 2024
18620671 SYSTEMS AND METHODS FOR OBTAINING NITROGEN AND CARBON DIOXIDE FROM A FLUE GAS American Ag Energy, Inc. NASSIRI MOTLAGH, ANITA 1734 §103 Final Rejection 2d overdue Pending Mar 28, 2024
18696885 PEST CONTROL APPARATUS AND METHODS Oxitec Limited CALLAWAY, SPENCER THOMAS 3642 §103§112 Non-Final OA — Pending Mar 28, 2024
18616044 SYSTEMS AND METHODS FOR INTRAOPERATIVE SURGICAL SCOPE CLEANING Stryker Corporation NEAL, TIMOTHY JAY 3795 §103 Final Rejection 4d overdue Pending Mar 25, 2024
18605796 GENETICALLY ALTERED NFR1 RECEPTOR KINASES Aarhus Universitet SHEN, YANXIN NMN 1663 §102§103§112 Final Rejection — Pending Mar 14, 2024
18605686 GENETICALLY ALTERED NFR5 RECEPTOR KINASES Aarhus Universitet LOGSDON, CHARLES 1662 §102§103§112 Non-Final OA — Pending Mar 14, 2024
18594344 DYE SUBLIMATION PRINTING PROCESSES Prism Inks, Inc. HIGGINS, GERARD T 1785 §103§112 Non-Final OA — Pending Mar 04, 2024
18590056 DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE Onelogy Inc. SPAINE, ROBERT FRANKLIN 1655 §101§103 Final Rejection — Pending Feb 28, 2024
18687542 PEPTIDE FOR DETECTING CA125 AND USE THEREOF Ajou University Industry-Academic Cooperation Foundation STEPHENS, AMELIA CAROLE §101§112 Non-Final OA — Pending Feb 28, 2024
18686366 SMART DENDROMETERS FOR TRACKING PLANT GROWTH Eplant, Inc. DUNLAP, JONATHAN M 2855 §103§112 Final Rejection 44d overdue Pending Feb 23, 2024
18686319 METHOD FOR GENERATING DOUBLE-STRANDED NUCLEIC ACID Dna Script ZAHORIK, AMANDA MARY §102§103§112 Non-Final OA — Pending Feb 23, 2024
18583410 AGENT ROUTE OPTIMIZATION USING QUANTUM COMPUTING Pwc Product Sales LLC STANDKE, ADAM C §103 Non-Final OA — Pending Feb 21, 2024
18582298 METHODS OF PRODUCING EMBOSSED CROSSLINKED POLYOLEFIN FOAMS Toray Plastics (America), Inc. RIOJA, MELISSA A §103§112 Non-Final OA — Pending Feb 20, 2024
18684082 ENGINEERED ADAR-RECRUITING RNAS AND METHODS OF USE THEREOF Edigene Therapeutics (Beijing) Inc. RIGA, MICHAEL ANGELO 1634 §102§103§112DP Non-Final OA — Pending Feb 15, 2024
18683172 A SKIN SUBSTITUTE COMPOSITION AND METHODS OF PRODUCING AND USING THE SAME Triovance Holding LLC PRONZATI, GINA 1633 §102§103§112 Non-Final OA — Pending Feb 12, 2024
18438160 SYSTEMS, DEVICES, AND METHODS FOR PREDICTING LANE LINE LOCATIONS Stack Av Co. KAUR, JASPREET 2662 §103 Final Rejection — Pending Feb 09, 2024
18438110 MULTIPLANE NANOPHOTONIC VOXEL ENGINE Massachusetts Institute Of Technology VU, PHU 2871 §102§103 Non-Final OA 46d overdue Pending Feb 09, 2024
18431481 QUANTUM COMPUTING APPROACHES FOR RESOURCE ALLOCATION Pwc Product Sales LLC SPRAUL III, VINCENT ANTON §101§103§112 Non-Final OA — Pending Feb 02, 2024
18294101 MICROBIOTA ENGINEERING Snipr Biome Aps GANGLE, BRIAN J 1645 §112 Non-Final OA — Pending Jan 31, 2024
18293326 COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF METHYL-CPG BINDING PROTEIN 2 (MECP2) Tune Therapeutics, Inc. KONOPKA, CATHERINE ANNE §101§102§103§112DP Non-Final OA — Pending Jan 29, 2024
18418090 PERMEATION ENHANCERS FOR GASTROINTESTINAL SYNTHETIC EPITHELIAL LININGS Syntis Bio, Inc. RONEY, CELESTE A 1612 §103§112 Non-Final OA — Pending Jan 19, 2024
18580508 AUTOMATICALLY DETERMINING THE PART(S) OF AN OBJECT DEPICTED IN ONE OR MORE IMAGES BAYER AKTIENGESELLSCHAFT CESE, KENNY A 2663 §103§112 Non-Final OA 16d Pending Jan 18, 2024
18415498 RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS Hofseth Biocare Asa BOECKELMAN, JACOB A 1655 §103§112 Non-Final OA 22d Pending Jan 17, 2024
18413999 MACHINE-LEARNING-BASED NETWORKING GRAPHICAL USER INTERFACE Pwc Product Sales LLC VU, KIEU D 2100 §102§103 Non-Final OA — Pending Jan 16, 2024
18414076 SYSTEMS AND METHODS FOR EVALUATING TRAINED MODELS Noblis, Inc. CHANNAVAJJALA, SRIRAMA T §101§103§112 Non-Final OA — Pending Jan 16, 2024
18579293 PREDICTION OF PHARMACOKINETIC CURVES Hoffmann-La Roche, Inc. HAYNES, DAWN TRINAH 3627 §101§102§103 Non-Final OA — Pending Jan 12, 2024
18573602 USE OF MAZDUTIDE Innovent Biologics (Suzhou) Co., Ltd. D' AMBROSIO, THEA 1654 §102§103§112DP Non-Final OA — Pending Dec 22, 2023
18573793 FEDERATED REPRESENTATION LEARNING WITH CONSISTENCY REGULARIZATION BAYER AKTIENGESELLSCHAFT STARKS, WILBERT L §101 Non-Final OA — Pending Dec 22, 2023
18542547 SYSTEMS AND METHODS FOR SHARPENING MEDICAL IMAGES Stryker Corporation TSAI, TSUNG YIN 2656 §103 Non-Final OA 29d Pending Dec 15, 2023
18542498 SYSTEMS AND METHODS FOR GUIDING DRILLED HOLE PLACEMENT IN ENDOSCOPIC PROCEDURES Stryker Corporation IP, JASON M 3797 §102§103 Non-Final OA — Pending Dec 15, 2023
18541719 SYNTHETIC ACTIVATION OF MULTIMERIC TRANSMEMBRANE RECEPTORS Aarhus Universitet CHATTERJEE, JAYANTA 1662 §102§103§112 Final Rejection 26d overdue Pending Dec 15, 2023
18540822 SYSTEMS AND METHODS FOR AMBIENT LIGHT COMPENSATION IN MEDICAL IMAGING Stryker Corporation CLOTHIER, MATTHEW MORRIS 2614 §102§103 Final Rejection — Pending Dec 14, 2023
18539645 METHOD AND COMPOSITION FOR DELIVERING A COMPOUND THROUGH A BIOLOGICAL BARRIER UNISA VENTURES PTY LTD HELM, CARALYNNE E 1615 §103§112DP Final Rejection 98d overdue Pending Dec 14, 2023
18538820 LOW-PROFILE WIDEBAND ANTENNA ARRAY CONFIGURED FOR CONNECTORLESS MOUNTING The MITRE Corporation SINGH, GURBIR 2845 §103 Non-Final OA 27d Pending Dec 13, 2023
18539090 VIDEO SURGICAL REPORT GENERATION Stryker Corporation MERCADO, GABRIEL S 2171 §103 Non-Final OA — Pending Dec 13, 2023
18537744 ACTIVE NOISE CANCELLATION IN A MEDICAL ENVIRONMENT Stryker Corporation FAHNERT, FRIEDRICH 2692 §103 Non-Final OA — Pending Dec 12, 2023
18536192 SYSTEMS AND METHODS FOR CONTROLLING A MEDICAL LIGHT VIA A HANDLE Stryker Corporation OKASHA, RAMI RAFAT 2118 §103 Final Rejection 28d Pending Dec 11, 2023
18568791 HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Zhejiang Genfleet Therapeutics Co., Ltd. VALENROD, YEVGENY 1628 §102§112Other Non-Final OA 11d overdue Pending Dec 08, 2023
18566197 BISPECIFIC BINDING MOLECULE BINDING TO VEGF AND ANG2 AND USE THEREOF Innovent Biologics (Suzhou) Co., Ltd. SZPERKA, MICHAEL EDWARD §112DP Non-Final OA — Pending Dec 01, 2023
18526959 HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR Genmab A/S SZPERKA, MICHAEL EDWARD 1641 §112DP Non-Final OA — Pending Dec 01, 2023
18523647 SOYBEAN VARIETIES '2993027', '3379006', '21808483', '21775353', '21775373', AND '21776015' Gdm Seeds Inc. ABRAHAM, AMJAD A 1663 §112DP Non-Final OA — Pending Nov 29, 2023
18521485 SYSTEMS AND METHODS FOR MODIFYING MUSICAL SIGNALS Fender Musical Instruments Corporation LAUGHLIN, CHARLES S 2846 §103 Non-Final OA — Pending Nov 28, 2023
18520308 MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND METHODS OF USING THE SAME Inhibrx Biosciences, Inc. BRISTOL, LYNN ANNE §103§112Other Non-Final OA — Pending Nov 27, 2023
18564488 ENGINEERED CAS12I NUCLEASE, EFFECTOR PROTEIN AND USE THEREOF BEIJING INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE LEITH, NANCY J 1683 §102§112 Non-Final OA — Pending Nov 27, 2023
18563824 C4 PLANTS WITH INCREASED PHOTOSYNTHETIC EFFICIENCY The Board Of Trustees Of The University Of Illinois SPEED, DEQUANTARIUS JAVON 1663 §103§112 Non-Final OA — Pending Nov 22, 2023
18563321 COMPOSITIONS FOR TREATING INSOMNIA AND USES THEREOF Zhejiang Jiachi Development Pharmaceuticals Ltd. MAHLUM, JONATHAN DAVIS 1625 §103 Non-Final OA — Pending Nov 21, 2023
18563261 XR MALL GENERATION DEVICE, CONTROL METHOD FOR XR MALL GENERATION DEVICE, AND XR MALL GENERATION PROGRAM Softbank Corp. POND, ROBERT M 3688 §103 Final Rejection — Pending Nov 21, 2023
18516803 MAGNETIC MICROCARRIERS FOR IMAGE DIFFERENTIATED MULTIPLEX ASSAYS Plexbio Co., Ltd. HOBBS, MICHAEL L 1672 §103 Non-Final OA — Pending Nov 21, 2023
18511630 QUANTUM-COMPUTING-ENHANCED SYSTEMS AND METHODS FOR ENTITY ALLOCATION Pwc Product Sales LLC WAESCO, JOSEPH M §101§103 Non-Final OA — Pending Nov 16, 2023
18290397 COUPLING FOR A GRINDING MILL LINER Bradken Resources Pty Limited PRESSLEY, PAUL DEREK 3725 §102 Final Rejection — Pending Nov 13, 2023
18289559 INHIBITION OF EOSINOPHILIC TRAPS Citryll B.V. MOSELEY II, NELSON B 1642 §103§112DP Non-Final OA — Pending Nov 03, 2023
18289331 GASTRIC RESIDENCE SYSTEMS COMPRISING BUPRENORPHINE AND NALOXONE Nortiva Bio, Inc. SCHMITT, MICHAEL J 1629 §103 Non-Final OA — Pending Nov 02, 2023
18289032 PEPTIDE-FC FUSIONS FOR TREATING AMYLOID DISORDERS Attralus, Inc. CHERNYSHEV, OLGA N 1675 §112 Non-Final OA — Pending Oct 31, 2023
18262628 OPHTHALMIC PREPARATION ADMINISTERED BY EYE DROPS AND USED FOR PREVENTING AND TREATING DRY MACULAR DEGENERATION AND RETINAL LIGHT DAMAGE Chengdu Ruimu Biopharmaceuticals Co., Ltd. RAO, SAVITHA M 1691 §103 Final Rejection — Pending Oct 31, 2023
18493568 ANTI-PD-1 ANTIBODIES AND USES THEREOF Tayu Huaxia Biotech Medical Group Co., Ltd. OUSPENSKI, ILIA I DP Non-Final OA — Pending Oct 24, 2023
18381550 PHARMACEUTICAL HYDRONIDONE FORMULATIONS FOR DISEASES Gyre Therapeutics, Inc. SZNAIDMAN, MARCOS L 1628 §103 Non-Final OA — Pending Oct 18, 2023
18555711 LIVER CANCER METHYLATION AND PROTEIN MARKERS AND THEIR USES Dhruvajyoti Roy JONES, CHRISTINE MICHELLE 1682 §101§102§112DP Non-Final OA — Pending Oct 16, 2023
18485535 HIGH EFFICIENCY TRANS-SPLICING FOR REPLACEMENT OF TARGETED RNA SEQUENCES IN HUMAN CELLS Tacit Therapeutics, Inc. ALLEN, SARAH ELIZABETH 1637 §101§102§103Other Non-Final OA — Pending Oct 12, 2023
18555123 CELL-CULTURED FOOD PRODUCTS AND RELATED CELLS, COMPOSITIONS, METHODS AND SYSTEMS Bluenalu, Inc. MARTIN, PAUL C 1653 §102§103§112 Non-Final OA — Pending Oct 12, 2023
18485224 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. ROMERO, KRISTEN WANG 1624 — Non-Final OA 15d Pending Oct 11, 2023
18480255 SYSTEMS AND METHODS FOR REMOTE TRANSACTION ASSESSMENTS Geocomply Solutions Inc. PINSKY, DOUGLAS W 3626 §103 Final Rejection — Pending Oct 03, 2023
18480087 X-RAY CALORIMETER Analex Corporation GERIDO, DWAN A 1797 §103 Non-Final OA — Pending Oct 03, 2023
18472987 COMPOSITION FOR PREVENTING OR TREATING OF ISCHEMIC CEREBROVASCULAR DISEASE COMPRISING AN ARGINASE-1 INHIBITOR Ajou University Industry-Academic Cooperation Foundation MARCSISIN, ELLEN JEAN 1677 §101§102§112 Non-Final OA — Pending Sep 22, 2023
18551570 BRAKE ARRANGEMENT FOR A TRACKED VEHICLE BAE Systems PLC WILLIAMS, THOMAS J 3616 §102§103 Non-Final OA — Pending Sep 20, 2023
18282506 COMPUTER-IMPLEMENTED METHODS AND SYSTEMS FOR QUANTITATIVELY DETERMINING A CLINICAL PARAMETER Hoffmann-La Roche, Inc. GLOVER, NELSON ALEXANDER 3791 §101§102§103§112 Non-Final OA 9d Pending Sep 15, 2023
18368303 ADAPTIVE SELECTION OF STIMULI FOR NEURO-ACTIVATION Click Therapeutics, Inc. SAHAND, SANA 3796 §101§103 Non-Final OA 164d overdue Pending Sep 14, 2023
18550432 METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF Triastek, Inc. BROWE, DAVID 1617 §101§102§112Other Non-Final OA — Pending Sep 13, 2023
18281265 ANTIBACTERIAL METHODS & CELLS Folium Food Science Limited OGUNBIYI, OLUWATOSIN A 1645 §102 Non-Final OA 17d overdue Pending Sep 08, 2023
18281216 IMMUNOMODULATORY MOLECULES AND USES THEREOF Immunowake Inc. SCHWECHTER, BRANDON ROSS 1674 §102§103§112 Non-Final OA 55d Pending Sep 08, 2023
18281163 METHOD FOR SILENCING GENES Tropic Biosciences UK Limited YU, DAVID TUYANG 1635 §103§112DP Non-Final OA — Pending Sep 08, 2023
18280458 ANTI-VISTA CONSTRUCTS AND USES THEREOF Dynamicure Biotechnology LLC HALVORSON, MARK 1646 §112 Non-Final OA — Pending Sep 05, 2023
18279038 METHOD FOR PRODUCING ALFALFA MOSAIC VIRUS-LIKE PARTICLES USING PLANT EXPRESSION SYSTEM AND USE THEREOF BIOAPPLICATIONS INC STOCKDALE, JESSICA NICOLE 1663 §103Other Final Rejection — Pending Aug 25, 2023
18278787 TARGETING CONJUGATES COMPRISING EFFECTOR MOLECULES AND USES THEREOF Allygen Group ALLEN, MARIANNE P 1647 §102§103DP Non-Final OA — Pending Aug 24, 2023
18453985 SYNOVIAL EXTRACELLULAR MATRIX-SPECIFIC CHIMERIC ANTIGEN RECEPTOR FOR TARGETING REGULATORY T CELLS TO TREAT AUTOIMMUNE DISEASES Curara AB SKELDING, ZACHARY S 1644 §103Other Non-Final OA — Pending Aug 22, 2023
18027594 Stabilized N-Terminally Truncated Terminal Deoxynucleotidyl Transferase Variants and Uses Thereof Dna Script SU-TOBON, QIWEN NMN 1636 §103§112DP Non-Final OA — Pending Aug 21, 2023
18452221 ADDITIVELY MANUFACTURED INTERNALLY METALIZED ANTENNA ARRAY APERTURE The MITRE Corporation ABRAHAM, JOSE K 3729 §102§103§112 Non-Final OA — Pending Aug 18, 2023
18546246 ANTI-CD3 ANTIBODIES AND METHODS OF USE THEREOF Adagene Pte. Ltd. HAM, JIEUN 1643 §102DP Non-Final OA — Pending Aug 11, 2023
18276845 METHODS AND COMPOSITIONS FOR DNA BASED KINSHIP ANALYSIS Verogen, Inc. PHAM, KHAI QUYNH TIEN §101§102§103 Non-Final OA — Pending Aug 10, 2023
18447874 FEDERATED LEARNING PLATFORM AND METHODS FOR USING SAME Devron Corporation TRUONG, THONG P 2433 §102§103§112 Non-Final OA — Pending Aug 10, 2023
18230973 COMPUTER GRAPHICAL INTERFACE PROCESSING WITH REMOTE COMPUTING DEVICES Click Therapeutics, Inc. WINSTON III, EDWARD B 3683 §101§103 Final Rejection — Pending Aug 07, 2023
18275978 MAP4K1 INHIBITORS Deutsches Krebsforschungszentrum LEE, CHIHYI NMN 1628 §103§112DP Non-Final OA — Pending Aug 04, 2023
18363976 ENGINEERED LEUCINE DECARBOXYLASES Syntis Bio , Inc. YU, DAVID TUYANG 1635 §112 Non-Final OA 43d Pending Aug 02, 2023
18363530 CRYOGENIC ELECTRON MICROSCOPY FULLY AUTOMATED ACQUISITION FOR SINGLE PARTICLE AND TOMOGRAPHY Health Technology Innovations, Inc. KAUR, JASPREET 2662 §101§103 Non-Final OA 28d Pending Aug 01, 2023
18361775 PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY Aurinia Pharmaceuticals Inc. HOLTZMAN, KATHERINE ANN 1646 §103 Final Rejection — Pending Jul 28, 2023
18358885 DEVICES THAT INCLUDE A DRIED REAGENT:SUBSTRATE COMPLEX AND METHODS FOR GENERATING SUCH COMPLEXES AND DEVICES Argonaut Manufacturing Services, Inc. SHI, TINGCHEN 1796 §103 Non-Final OA — Pending Jul 25, 2023
18357613 SYSTEMS AND METHODS FOR HUMAN-MACHINE PARTNERED PTSD PREDICTION The MITRE Corporation EDWARDS, PHILIP CHARLES 3792 §101§103 Final Rejection 98d overdue Pending Jul 24, 2023
18355195 METHODS FOR TREATING NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY Cytokinetics, Incorporated REDWOOD, CHRISTOPHER EVAN 1629 §102§103DP Non-Final OA — Pending Jul 19, 2023
18353355 SCAFFOLDING SYSTEM Gramercy Group Inc. CHAVCHAVADZE, COLLEEN MARGARET 3634 §103 Final Rejection 6d Pending Jul 17, 2023
18272786 GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF RISPERIDONE Nortiva Bio, Inc. PEEBLES, KATHERINE 1617 DP Final Rejection 88d overdue Pending Jul 17, 2023
18220728 DEVICES AND METHODS FOR PREPARING HUMAN MILK ORIGIN FORTIFIER COMPOSITIONS BABYLAT AG KERR, ELIZABETH M 3761 §103 Non-Final OA — Pending Jul 11, 2023
18349083 ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF Viromissile, Inc. ALLEN, MICHAEL D 1671 §103§112 Non-Final OA — Pending Jul 07, 2023
18348793 METHOD AND SYSTEM FOR INTEGRATED MONITORING OF CHATBOTS FOR CONCEPT DRIFT DETECTION Pwc Product Sales LLC MCCORD, PAUL C 2692 §103§112 Final Rejection 28d Pending Jul 07, 2023
18271416 SPEECH-ANALYSIS BASED AUTOMATED PHYSIOLOGICAL AND PATHOLOGICAL ASSESSMENT UNIVERSITÄTSSPITAL BASEL TENGBUMROONG, NATHAN NARA 2654 DP Non-Final OA 42d overdue Pending Jul 07, 2023
18218708 APPARATUS FOR CHARACTERIZING PARTICLES AND METHOD FOR USE IN CHARACTERIZING PARTICLES Malvern Panalytical Limited KISS, ERIC B 3992 §102 Non-Final OA — Pending Jul 06, 2023
18346185 SYSTEMS AND METHODS FOR DISPLAYING MEDICAL IMAGING DATA Stryker Corporation CHU, RANDOLPH I 2667 §103 Non-Final OA — Pending Jun 30, 2023
18217362 REVERSAL OF CELLULAR SENESCENCE BY TREATMENT WITH LOW FREQUENCY ULTRASOUND Mechanobiologics, Inc. POPESCU, GABRIEL VICTOR 3797 §103 Final Rejection 3d overdue Pending Jun 30, 2023
18268560 BIOSENSOR USING PET SUBSTRATE, FABRICATION METHOD THEREFOR, AND METHOD FOR INSPECTING SENSITIVITY OF MICROORGANISM TO ANTIBIOTIC BY USING SAME Proteometech Inc. QIAN, SHIZHI 1795 §102 Non-Final OA 14d Pending Jun 20, 2023
18267764 ADENO-ASSOCIATED VIRUS CAPSIDS AND VECTORS Children'S Medical Research Institute SPENCER, ANDREA LYNNE MORRIS 1631 §103§112 Non-Final OA — Pending Jun 15, 2023
18335687 DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF Shionogi & Co., Ltd. CHAO, ALLEN 1622 §112 Final Rejection 9d Pending Jun 15, 2023
18267411 MASS SPECTROMETRY SAMPLE PROCESSING METHODS, CHROMATOGRAPHY DEVICES, AND DATA ANALYSIS TECHNIQUES FOR BIOMARKER ANALYSIS Proteas Bioanalytics, Inc. ALABI, OYELEYE A 1797 §101§103§112 Non-Final OA — Pending Jun 14, 2023
18334342 SYSTEMS AND METHODS FOR MONITORING SURGICAL WORKFLOW AND PROGRESS Stryker Corporation SHELDEN, BION A 3685 §101§102§103 Final Rejection 7d Pending Jun 13, 2023
18334336 OPERATING ROOM MONITORING AND ALERTING SYSTEM Stryker Corporation EVANS, ASHLEY ELIZABETH 3687 §103 Final Rejection 33d Pending Jun 13, 2023
18267083 METHOD FOR QUANTIFYING CPG-CONTAINING OLIGONUCLEOTIDES IN COMPOSITIONS COMPRISING ALUM Dynavax Technologies Corporation SITTON, JEHANNE SOUAYA 1682 §103§112 Non-Final OA — Pending Jun 13, 2023
18334344 SYSTEMS AND METHODS FOR NON-COMPLIANCE DETECTION IN A SURGICAL ENVIRONMENT Stryker Corporation CHOI, DAVID 3684 §101 Non-Final OA 6d Pending Jun 13, 2023
18256776 CANCER TREATMENT USING BOSENTAN IN COMBINATION WITH A CHECKPOINT INHIBITOR University of Cyprus BELL, SARA ELIZABETH 1625 §101§102§103§112DP Non-Final OA — Pending Jun 09, 2023
18266149 METHODS OF DETECTING PAPP-A AND RELATED METHODS FOR GESTATIONAL AGE ASSESSMENT The Board Of Trustees Of University Of Illinois GAO, ASHLEY HARTMAN 1678 §101§103 Non-Final OA — Pending Jun 08, 2023
18266231 BUCKET Bradken Resources Pty Limited LUSK, AUDREY L 3671 §102§103 Final Rejection — Pending Jun 08, 2023
18265218 PHOTO-CROSSLINKED HYALURONIC ACID BIO-INK FOR BIO-PRINTING, METHOD FOR PREPARING SAME, AND BIOLOGICAL STRUCTURE CAPABLE OF CONTROLLING PHYSICAL PROPERTIES USING SAME Ajou University Industry-Academic Cooperation Foundation KAUCHER, MARK S 1764 §102§103 Final Rejection 14d Pending Jun 02, 2023
18039608 FUSIONS OF MUTANT INTERLEUKIN-10 POLYPEPTIDES WITH ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION Asher Biotherapeutics, Inc. JOHANSEN, PETER N. 1644 §102§103§112 Non-Final OA — Pending May 31, 2023
18321538 SYSTEMS AND METHODS FOR CONSTRUCTING TOPIC-SPECIFIC KNOWLEDGE GRAPHS Pricewaterhousecoopers LLP MIAN, MUHAMMAD U 2163 §101 Final Rejection 7d Pending May 22, 2023
18037986 VECTOR SYSTEM FOR DELIVERY OF MULTIPLE POLYNUCLEOTIDES AND USES THEREOF Umoja BioPharma, Inc. BATES, KEENAN ALEXANDER 1631 §102DP Final Rejection 30d Pending May 19, 2023
18253726 COMPOUNDS AS PU. 1 INHIBITORS Peking University MCDOWELL, BRIAN E 1624 §112 Final Rejection 29d overdue Pending May 19, 2023
18036382 RESPIRATORY TREATMENTS Hofseth Biocare Asa HIBBERT, CATHERINE S 1658 §102§112DP Non-Final OA — Pending May 10, 2023
18314755 PHAGE AND TRANSDUCTION PARTICLES Snipr Biome Aps VIVLEMORE, TRACY ANN 1638 §103§112 Final Rejection — Pending May 09, 2023
18143989 ADAPTIVE SELECTION OF MESSAGES FOR TRANSMISSION IN NETWORKED ENVIRONMENTS TO INCREASE SESSION ADHERENCE Click Therapeutics, Inc. HOLCOMB, MARK 3685 §101§103 Non-Final OA 128d overdue Pending May 05, 2023
18143506 GENOME EDITING USING EFFECTOR OLIGONUCLEOTIDES FOR THERAPEUTIC TREATMENT Research Foundation To Cure Aids, Inc. BURKHART, MICHAEL D 1638 §102§103 Non-Final OA — Pending May 04, 2023
18034487 Enzymatic Synthesis of Polynucleotide Probes Dna Script YU, DELPHINUS DOU YI 1656 §112 Non-Final OA — Pending Apr 28, 2023
18034289 ANTIGEN BINDING MOLECULES AND USES THEREOF Agency for Science, Technology and Research PAK, MICHAEL D 1674 §102§112Other Non-Final OA — Pending Apr 27, 2023
18308339 JOURNAL ENTRY PARSING Pwc Product Sales LLC MOORE, REVA R 3627 §103 Non-Final OA 20d Pending Apr 27, 2023
18032784 PROTEOGLYCAN CONJUGATE AND APPLICATION THEREOF Shanghai Microdom Biotech Co., Ltd. OGUNBIYI, OLUWATOSIN A 1645 §101§102§112 Non-Final OA 2d overdue Pending Apr 19, 2023
18300934 METHOD AND APPARATUS TO EXTRACT CLIENT DATA WITH CONTEXT USING ENTERPRISE KNOWLEDGE GRAPH FRAMEWORK Pwc Product Sales LLC MEINECKE DIAZ, SUSANNA M 3625 §101§102 Final Rejection 50d overdue Pending Apr 14, 2023
17916256 CATALYST FOR THE GENERATION OF HYDROGEN AND/OR SYNTHESIS GAS, METHOD FOR OBTAINING SAME AND USE IN A STEAM REFORMING PROCESS UNIVERSIDADE FEDERAL DO RIO DE JANEIRO TAYLOR, JORDAN W 1738 §103 Final Rejection 12d Pending Apr 12, 2023
18298998 METHODS OF SCREENING FOR PLANT GAIN OF FUNCTION MUTATIONS AND COMPOSITIONS THEREFOR The Regents of the University of California CHATTERJEE, JAYANTA 1662 §112 Final Rejection 22d overdue Pending Apr 11, 2023
18194472 PLATFORM FOR ASSESSING AND TREATING INDIVIDUALS BY SOURCING INFORMATION FROM GROUPS OF RESOURCES Trayt Health Inc. SASS, KIMBERLY A. 3686 §101 Final Rejection — Pending Mar 31, 2023
18194320 METHODS OF MAKING CROSSLINKED POLYETHYLENE FOAM Toray Plastics (America), Inc. MUSSER, BARBARA J 1746 §103 Final Rejection — Pending Mar 31, 2023
18194316 CROSSLINKED POLYETHYLENE FOAM Toray Plastics (America), Inc. VO, HAI 1788 §103 Final Rejection 56d overdue Pending Mar 31, 2023
18191583 VERTICAL FEDERATED LEARNING PLATFORM AND METHODS FOR USING SAME Devron Corporation TRUONG, THONG P 2433 §103 Non-Final OA — Pending Mar 28, 2023
18189896 TRANS-SPLICING SYSTEM FOR TISSUE-SPECIFIC REPLACEMENT OF RNA SEQUENCES Tacit Therapeutics, Inc. DACE DENITO, ALEXANDRA GERALDINE 1636 §112DP Non-Final OA — Pending Mar 24, 2023
18028502 ACTIVATED PLURIPOTENT STEM CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF BEIJING INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE WILSON, MICHAEL C 1638 §102§112Other Non-Final OA 27d Pending Mar 24, 2023
18027847 SYNTHETIC VIRUSES Snipr Biome Aps CHEN, STACY BROWN 1672 §102§112DPOther Final Rejection — Pending Mar 22, 2023
18027005 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING Neuropore Therapies, Inc. COUGHLIN, MATTHEW P 1626 §102§103§112Other Non-Final OA 22d Pending Mar 17, 2023
18120074 HIGH-FILTRATION REUSABLE FACE MASK WITH TEXTURED CONTACT PORTION AND VARIOUS COUPLING MECHANISMS Teal Bio, Inc. HUSSAIN, MISHAL ZAHRA 3785 §103§112 Non-Final OA — Pending Mar 10, 2023
18177085 DEVICES THAT INCLUDE A DRIED REAGENT:SUBSTRATE COMPLEX AND METHODS FOR GENERATING SUCH COMPLEXES AND DEVICES Argonaut Manufacturing Services, Inc. MONTGOMERY, ANN Y 1678 §112 Final Rejection 42d Pending Mar 01, 2023
18116196 METHODS FOR MULTIMODAL EPIGENETIC SEQUENCING ASSAYS The Regents of the University of California WISE, OLIVIA M. §101§102§103§112 Non-Final OA — Pending Mar 01, 2023
18024014 CELL CULTURE SOLUTION CONTAINER AND DISPENSER Stoic Bio, Inc. RAMIREZ, ALEX 1798 §103 Final Rejection — Pending Feb 28, 2023
18023656 POLYAMIDE REVERSE OSMOSIS MEMBRANE HAVING EXCELLENT DURABILITY AND ANTIFOULING PROPERTIES, AND METHOD FOR MANUFACTURING SAME Toray Advanced Materials Korea Inc. HUANG, RYAN 1777 §103Other Non-Final OA 15d overdue Pending Feb 27, 2023
18174000 INTELLIGENT SYSTEMATIC AGENT: AN ENSEMBLE OF DEEP LEARNING AND EVOLUTIONARY STRATEGIES Pwc Product Sales LLC SUSSMAN MOSS, JACOB ZACHARY 2122 §101§103 Final Rejection 66d overdue Pending Feb 24, 2023
18023060 MODIFIED IMMUNE CELLS FOR FIBROSIS AND INFLAMMATION Resolution Therapeutics Limited DUFFY, BRADLEY 1643 §102§103 Final Rejection 1d overdue Pending Feb 24, 2023
18022084 METHOD AND DRUG FOR TUMOR TREATMENT Talengen International Limited SAIDHA, TEKCHAND 1652 §102§112 Non-Final OA — Pending Feb 17, 2023
18041884 SYSTEM FOR IMPROVING FLEXIBILITY OF RISER SUPPORTS IN STATIONARY PRODUCTION UNITS AND INSTALLATION METHOD Petróleo Brasileiro S.A. - Petrobras LAMBE, PATRICK F 3676 §103 Final Rejection — Pending Feb 16, 2023
18020242 COMPOUNDS AS C5AR INHIBITORS Kira Pharmaceuticals (Suzhou) Ltd. KUCKLA, ANNA GRACE 1626 §103 Final Rejection 22d overdue Pending Feb 07, 2023
18016307 GATED ADAPTER TARGETING RECEPTOR Umoja BioPharma, Inc. HOWARD, ZACHARY C 1674 §112 Non-Final OA — Pending Jan 13, 2023
18016304 CHIMERIC MYD88 RECEPTORS FOR REDIRECTING IMMUNOSUPPRESSIVE SIGNALING AND RELATED COMPOSITIONS AND METHODS Children'S Hospital Los Angeles PATTERSON, SARAH COOPER 1675 §112 Non-Final OA — Pending Jan 13, 2023
18014729 ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDES TO SAID CELLS Hoffmann-La Roche, Inc. CABRAL, ROBERT S 1614 Other Non-Final OA — Pending Jan 05, 2023
18093450 MULTI-FACTOR TRANSITION INTO OR OUT OF AUTONOMY Stack Av Co. NGUYEN, NGA X 3662 §103 Final Rejection 75d Pending Jan 05, 2023
18149627 COMPOSITIONS AND METHODS FOR INCREASING SHELF-LIFE OF BANANA Tropic Biosciences UK Limited SULLIVAN, BRIAN JAMES 1663 §103 Non-Final OA 89d overdue Pending Jan 03, 2023
18092911 GENOME EDITING OF HUMAN NEURAL STEM CELLS USING NUCLEASES BOCO Silicon Valley, Inc. LEONARD, ARTHUR S 1631 §103DP Non-Final OA — Pending Jan 03, 2023
18014056 ARTIFICIAL SKIN HAVING STRUCTURE AND PROPERTIES BY AGE, AND METHOD FOR PRODUCING SAME Foundation Of Soongsil University-Industry Cooperation MARTIN, PAUL C 1653 §103§112 Non-Final OA — Pending Dec 30, 2022
18087453 ORGANOMINERAL FERTILIZER Petróleo Brasileiro S.A. - Petrobras SMITH, JENNIFER A 1731 §112 Non-Final OA — Pending Dec 22, 2022
18069976 SYSTEMS AND METHODS FOR IMAGE-BASED ANALYSIS OF ANATOMICAL FEATURES Stryker Corporation MATTSON, SEAN D 3798 §103 Final Rejection 70d overdue Pending Dec 21, 2022
18010783 ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER Genmab A/S BELYAVSKYI, MICHAIL A 1644 §103DP Final Rejection 7d Pending Dec 15, 2022
18081483 DATA ANALOG IDENTIFICATION METHOD Petróleo Brasileiro S.A. - Petrobras SCHWARZENBERG, PAUL §101 Final Rejection 11d overdue Pending Dec 14, 2022
18077814 MICROFLUIDIC SYSTEM FOR OIL SAMPLE ANALYSIS Cnpem - Centro Nacional De Pesquisa Em Energia E Materiais HERBERT, MADISON TAYLOR 1758 §103 Non-Final OA — Pending Dec 08, 2022
18059969 SYSTEMS AND METHODS FOR CONNECTING A MEDICAL IMAGING DEVICE TO A MEDICAL IMAGING CONTROLLER Stryker Corporation BRUCKART, BENJAMIN R 2424 §103 Final Rejection — Pending Nov 29, 2022
18071218 ANATOMICAL GRIPPING SYSTEM FOR GRIPPING THE LEG AND FOOT OF A PATIENT WHEN EFFECTING HIP DISTRACTION AND/OR WHEN EFFECTING LEG POSITIONING Stryker Corporation MILLER, DANIEL A 3786 §103§112 Final Rejection — Pending Nov 29, 2022
17991859 HORIZONTAL WELL PRODUCTION METHOD WITH UNIFORM FLOW Petróleo Brasileiro S.A. - Petrobras KIM, EUNHEE 2187 §103 Final Rejection — Pending Nov 22, 2022
17926546 MEDIA FORMULATIONS AND PRODUCTION Nucleus Biologics SMITH, JENNIFER JOY 1685 §101§102§103§112 Non-Final OA — Pending Nov 18, 2022
17926160 USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION Sorbonne Universite RAMIREZ, DELIA M 1652 §103§112Other Final Rejection — Pending Nov 18, 2022
17989829 RHEOLOGICAL MODEL OF WATER-IN-OIL EMULSIONS OBTAINED BY ARTIFICIAL INTELLIGENCE Petróleo Brasileiro S.A. - Petrobras GEBRESILASSIE, KIBROM K 2189 §101§103 Final Rejection 8d overdue Pending Nov 18, 2022
18056237 SYSTEMS AND METHODS FOR COMPENSATING FOR OBSTRUCTIONS IN MEDICAL IMAGES Stryker Corporation MILIA, MARK R 2681 §103 Final Rejection 22d overdue Pending Nov 16, 2022
17924540 COMPOSITIONS AND METHODS FOR TREATING CANCER Adagene AG KAUFMAN, CLAIRE M 1674 §102Other Final Rejection 26d Pending Nov 10, 2022
17984692 METHOD FOR MODELING THE DAMAGE ZONE OF FAULTS IN FRACTURED RESERVOIRS Petróleo Brasileiro S.A. - Petrobras ALHIJA, SAIF A 2186 §102§103 Final Rejection 7d Pending Nov 10, 2022
17983606 METHOD FOR UNIFORMIZATION OF FLOW FOR STIMULATION OPERATIONS Petróleo Brasileiro S.A. - Petrobras MOLL, NITHYA JANAKIRAMAN 2189 §101§112 Final Rejection 15d Pending Nov 09, 2022
17980366 CREATING DIGITAL TWINS AT SCALE Pwc Product Sales LLC MOLL, NITHYA JANAKIRAMAN 2189 §101§112Other Non-Final OA 63d Pending Nov 03, 2022
17976117 POLYMER NANOCOMPOSITE FOR USE IN ELECTRICAL AND ELECTRONIC EQUIPMENT WITH PROPERTIES SUITABLE FOR APPLICATIONS SUCH AS ELECTRICAL INSULATION AND WITH THERMAL CONDUCTIVITY GAIN Petróleo Brasileiro S.A. - Petrobras CAI, WENWEN 1763 §103§112 Final Rejection 45d overdue Pending Oct 28, 2022
17976659 PROCUREMENT MODELING SYSTEM FOR PREDICTING PREFERENTIAL SUPPLIERS AND SUPPLIER PRICING POWER Arkestro Inc. NGUYEN, NGA B 3625 §112 Non-Final OA 45d overdue Pending Oct 28, 2022
17971875 METHOD OF AUTOMATIC CHARACTERIZATION AND REMOVAL OF PAD ARTIFACTS IN ULTRASONIC IMAGES OF WELLS Centro Brasileiro De Pesquisas Físicas - Cbpf CHU, RANDOLPH I 2667 §102 Non-Final OA 27d Pending Oct 24, 2022
17970868 COMBINED METHOD FOR ESTIMATING INJECTIVITY LOSS IN CARBONATE RESERVOIRS Petróleo Brasileiro S.A. - Petrobras DEBNATH, NUPUR 2186 §103§112 Non-Final OA — Pending Oct 21, 2022
17967831 COMPOSITION FOR PROMOTING ANGIOGENESIS USING LIQUID TYPE PLASMA AND METHOD FOR PROMOTING ANGIOGENESIS USING SAME Ajou University Industry-Academic Cooperation Foundation PRICE, NATHAN R 3783 §112 Non-Final OA 10d overdue Pending Oct 17, 2022
17918316 METHOD FOR DETECTING GENETIC EVENTS Stilla Technologies VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103 Non-Final OA — Pending Oct 11, 2022
17918093 OSTEOBLASTS DIFFERENTIATED FROM MESENCHYMAL STEM CELLS AND COMPOSITION FOR TREATING BONE DISEASE COMPRISING SAME Cefo Co., Ltd. TICHY, JENNIFER M.H. 1653 §103 Final Rejection — Pending Oct 10, 2022
17937866 SYSTEMS AND METHODS FOR CONFIGURING AND DEPLOYING A PORTABLE FIELD-DEPLOYABLE BIOSURVEILLANCE KIT Noblis, Inc. FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§103§112 Non-Final OA — Pending Oct 04, 2022
17916482 PONGAMIA OIL COMPOSITIONS, AND METHODS FOR PRODUCING AND USING THEREOF Terviva, Inc. SHELLHAMMER, JAMES PAUL 1793 §103§112 Final Rejection 1d overdue Pending Sep 30, 2022
17916529 PONGAMIA OIL COMPOSITIONS, AND METHODS FOR PRODUCING AND USING THEREOF Terviva, Inc. SHELLHAMMER, JAMES PAUL 1793 §103 Final Rejection 21d Pending Sep 30, 2022
17915086 METHODS, COMPOSITIONS, AND SYSTEMS FOR ENHANCING EX-VIVO ORGAN PERFUSION UNIVERSITY HEALTH NETWORK NGUYEN, NGHI V 1653 §103 Final Rejection — Pending Sep 27, 2022
17941369 SYSTEMS AND METHODS FOR ONBOARDING AND SUPPORTING CREDIT PRODUCT PARTNERS Mercury Financial Holdings LLC GREGG, MARY M 3695 §101§103 Non-Final OA 167d overdue Pending Sep 09, 2022
17884724 METHOD OF PREPARING THE WATER-GAS SHIFT CATALYST, CATALYST, USE AND PROCESS TO REDUCE THE CONTENT OF CARBON MONOXIDE Petróleo Brasileiro S.A. - Petrobras ZHANG, KELING NMN 1732 §103 Non-Final OA — Pending Aug 10, 2022
17798824 METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA Talengen International Limited BERKE-SCHLESSEL, DAVID W 1651 §102§103§112 Non-Final OA 259d overdue Pending Aug 10, 2022
17817653 SYSTEMS AND METHODS FOR INTRAOPERATIVE SURGICAL SCOPE CLEANING Stryker Corporation HARRIS, WESLEY G 3783 §102§103 Final Rejection — Pending Aug 04, 2022
17796563 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES Maze Therapeutics, Inc. WHITEMAN, BRIAN A 1636 §101§102§103§112DP Final Rejection 58d overdue Pending Jul 29, 2022
17795829 ANTI-CD30 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA Celgene Corporation SHUPE, ELIZABETH A 1643 §103 Non-Final OA — Pending Jul 27, 2022
17759282 HETERODIMERIC PROTEINS WITH FC MUTATIONS Adagene AG BRISTOL, LYNN ANNE 1643 §103§112DP Non-Final OA 15d Pending Jul 21, 2022
17793371 METHOD FOR TREATMENT OF NERVE INJURY AND RELATED DISEASE Talengen International Limited REYNOLDS, FRED H 1658 §103§112DP Non-Final OA — Pending Jul 15, 2022
17811863 WIRELESS ENDOSCOPIC CAMERA WITH IMAGE COMPRESSION Stryker Corporation CHOU, WILLIAM B 3795 §103 Final Rejection — Pending Jul 11, 2022
17854329 AI-AUGMENTED AUDITING PLATFORM INCLUDING TECHNIQUES FOR AUTOMATED ASSESSMENT OF VOUCHING EVIDENCE Pricewaterhousecoopers LLP WERONSKI, MATTHEW S 3627 §101§103 Non-Final OA — Pending Jun 30, 2022
17809491 ROAD NETWORK DATA PROCESSING METHOD, ELECTRONIC DEVICE, AND STORAGE MEDIUM BEIJING BAIDU NETCOM SCIENCE TECHNOLOGY CO., LTD. ALKIRSH, AHMED 3668 §103 Non-Final OA 187d overdue Pending Jun 28, 2022
17843917 METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS Hryz Biotech Co. MARVICH, MARIA 1634 §112Other Final Rejection 18d overdue Pending Jun 17, 2022
17843912 METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS Hryz Biotech Co. MARVICH, MARIA 1634 §112DP Final Rejection 46d overdue Pending Jun 17, 2022
17757555 MACROLIDE COMPOUND AND ITS USE OF TREATMENT CHRONIC RESPIRATORY DISEASE BEIJING CONTINENT PHARMACEUTICALS CO., LTD. O DELL, DAVID K 1621 §103 Non-Final OA — Pending Jun 16, 2022
17782111 METHODS FOR ENHANCING IMMUNITY AND TUMOR TREATMENT Rakuten Medical, Inc. BUTTICE, AUDREY L 1647 §103Other Final Rejection — Pending Jun 02, 2022
17774128 POLYMERIC LINKERS FOR A GASTRIC RESIDENCE SYSTEM Nortiva Bio, Inc. GREENE, IVAN A 1619 §103 Non-Final OA — Pending May 03, 2022
17770986 CHIMERIC CYTOKINE MODIFIED ANTIBODIES AND METHODS OF USE THEREOF Minotaur Therapeutics, Inc. PATTERSON, SARAH COOPER 1675 §102§103DP Final Rejection — Pending Apr 21, 2022
17721091 MODEL-BASED SYSTEM ENGINEERING ANALYSIS TOOL FOR DIGITAL MODELING OF SYSTEMS OF SYSTEMS The MITRE Corporation GEBRESILASSIE, KIBROM K 2189 §103§112 Final Rejection 46d overdue Pending Apr 14, 2022
17682276 KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Haemalogix Ltd. DUFFY, BRADLEY 1643 §103DP Final Rejection — Pending Feb 28, 2022
17651412 SYSTEMS AND METHODS FOR CONTROLLING A SURGICAL PUMP USING ENDOSCOPIC VIDEO DATA Stryker Corporation DUONG, HIEN LUONGVAN 2147 §103 Non-Final OA 73d overdue Pending Feb 16, 2022
17634930 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES Deutsches Krebsforschungszentrum LEE, ANDREW P 1691 §112 Non-Final OA — Pending Feb 11, 2022
17633568 PREDICTION OF RESIDUES OF PLANT PROTECTION AGENTS IN HARVESTED PRODUCTS BAYER AKTIENGESELLSCHAFT SIMS, JASON M 3791 §101§112 Non-Final OA — Pending Feb 07, 2022
17666272 CATALYSTS, PROCESS FOR OBTAINING AND STEAM PRE-REFORMING PROCESS OF HYDROCARBONS Petróleo Brasileiro S.A. - Petrobras SPEER, JOSHUA MAXWELL 1736 §103 Final Rejection 1d overdue Pending Feb 07, 2022
17632756 CETUXIMAB-IR700 CONJUGATE COMPOSITIONS Rakuten Medical, Inc. MIDDLETON, DANAYA L 1674 §112 Non-Final OA — Pending Feb 03, 2022
17629322 Increasing Long-Sequence Yields In Template-Free Enzymatic Synthesis of Polynucleotides Dna Script YAMASAKI, ROBERT J 1657 §103§112 Non-Final OA 27d Pending Jan 21, 2022
17579262 AUTOMATED DATA SET PROCESSING AND VISUALIZATION FOR MULTI-MODULE PRICING INSIGHTS GRAPHICAL USER INTERFACE Pwc Product Sales LLC CURRAN, J MITCHELL 2169 §103 Final Rejection — Pending Jan 19, 2022
17579194 SYSTEMS AND METHODS FOR PROCESSING BIOLOGICAL SIGNALS Elemind Technologies, Inc. MERRIAM, AARON ROGERS 3791 §103 Non-Final OA — Pending Jan 19, 2022
17572170 PRIMER DESIGN USING INDEXED GENOMIC INFORMATION Noblis, Inc. ZEMAN, MARY K 1686 Other Final Rejection — Pending Jan 10, 2022
17620580 SYSTEM FOR LAUNCHING EQUIPMENT WITH A CABLE FOR INTERNALLY INSPECTING AND UNBLOCKING PRODUCTION, INJECTION AND DISTRIBUTION DUCTS Servico Nacional De Aprendizagem Industrial - Departamento Regional De Santa Catrina Sanai/Sc ROST, ANDREW J 3753 §103 Non-Final OA — Pending Dec 17, 2021
17612989 PHARMACEUTICAL COMBINATION Agency for Science, Technology and Research GONZALEZ, LUISALBERTO 1624 §112 Non-Final OA 5d overdue Pending Nov 19, 2021
17608408 GAZE PREDICTOR Pwc Product Sales LLC LI, JAI WEI TOMMY 2613 §103§112 Final Rejection — Pending Nov 02, 2021
17516273 CHEESE AND YOGURT LIKE COMPOSITIONS AND RELATED METHODS New Culture Inc. MCCLAIN, TYNESHA L. 1793 §103 Non-Final OA — Pending Nov 01, 2021
17602895 COMPREHENSIVE DETECTION OF SINGLE CELL GENETIC STRUCTURAL VARIATIONS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. ZEMAN, MARY K 1686 §101§102§112Other Non-Final OA — Pending Oct 11, 2021
17497876 SYSTEMS AND METHODS FOR MITIGATING FOGGING IN ENDOSCOPIC IMAGING Stryker Corporation BOICE, JAMES EDWARD 3795 §103 Non-Final OA 4d overdue Pending Oct 08, 2021
17599446 EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS Turnstone Biologics Corp. RAHMAN, MASUDUR 1633 §102§103 Final Rejection 7d Pending Sep 28, 2021
17477419 COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY Rakuten Medical, Inc. PERREIRA, MELISSA JEAN 1618 §103Other Final Rejection 58d overdue Pending Sep 16, 2021
17438792 METHODS OF ENHANCING BIOMASS IN A PLANT THROUGH STIMULATION OF RUBP REGENERATION AND ELECTRON TRANSPORT University of Essex Enterprises Limited SPEED, DEQUANTARIUS JAVON 1663 §103§112 Non-Final OA 4d overdue Pending Sep 13, 2021
17469804 COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY Rakuten Medical, Inc. PERREIRA, MELISSA JEAN 1618 §103§112 Non-Final OA — Pending Sep 08, 2021
17310754 METHODS AND COMPOSITIONS FOR REPELLING BIRDS IN CROP PLANTS BAYER AKTIENGESELLSCHAFT MAEWALL, SNIGDHA 1612 §103 Final Rejection 34d Pending Aug 20, 2021
17431903 CELL PENETRATING TRANSPOSASE Julius-Maximilians-Universität Würzburg QIAN, CELINE X 1637 Other Non-Final OA — Pending Aug 18, 2021
17428591 ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF Avive Solutions, Inc. PEEBLES, KATHERINE 1617 §103§112Other Final Rejection 124d overdue Pending Aug 04, 2021
17366278 Systems, Methods, and Devices for Generating and Administering Digital Therapeutic Placebos and Shams Click Therapeutics, Inc. FURTADO, WINSTON RAHUL 3687 §101§103 Final Rejection 56d Pending Jul 02, 2021
17419260 IMMUNOCHROMATOGRAPHY STRIP FOR PREGNANCY DIAGNOSIS WITH MULTIPLE TEST LINES, AND PREGNANCY DIAGNOSIS KIT COMPRISING SAME Proteometech Inc. KIRWIN, STEFANIE JOHANNA 1677 §103§112 Final Rejection — Pending Jun 28, 2021
17290204 SYSTEMS, METHODS, AND APPARATUSES FOR MANAGING DATA FOR ARTIFICIAL INTELLIGENCE SOFTWARE AND MOBILE APPLICATIONS IN DIGITAL HEALTH THERAPEUTICS Click Therapeutics, Inc. BARR, MARY EVANGELINE 3682 — Non-Final OA — Pending Apr 29, 2021
17229746 COPPER LOSS MITIGATION Genentech, Inc. MIANO, JOSEPH PAUL 1631 §102§103§112 Final Rejection 9d Pending Apr 13, 2021
17283939 ANIMAL MODELS AND THERAPEUTIC MOLECULES Genome Research Limited GODDARD, LAURA B 1642 §103§112 Non-Final OA 56d Pending Apr 08, 2021
16973749 FISH PROTEIN HYDROLYSATE POWDER AND A COMPOSITION COMPRISING SAID POWDER FOR USE AS A MEDICAMENT Hofseth Biocare Asa KIM, BRYAN 1792 §103 Non-Final OA 33d Pending Dec 09, 2020
16863228 Systems and Methods for Clinical Curation of Crowdsourced Data Click Therapeutics, Inc. COBANOGLU, DILEK B 3687 §101 Non-Final OA — Pending Apr 30, 2020
16648779 MODIFYING THE SPECIFICITY OF NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION IN EUKARYOTIC CELLS Tropic Biosciences UK Limited VYAS, KEYUR ANILKUMAR 1637 §103DP Final Rejection — Pending Mar 19, 2020

Managing Morrison & Foerster LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month